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With the discovery of DNA, the completion of genome sequencing
of a number of organisms, and the advent of powerful high-through-
put measurement technologies such as microarrays, it is now com-
monly said that biology has gone through a revolution. But I also
have heard it said that biology is only about to go through a scientific
revolution, much as physics did in the 17th century. In messianic
hopes, people foretell the coming of the Newton of biology, but it is
up to us, the scientific community, to set the stage for that to happen.
Both views are valid, each in their own sense. The discovery of
DNA and the more recent development of powerful new technologies
have certainly revolutionized our understanding of the inner workings
of life and allowed us to probe deep into the machinery of living organ-
isms, much as the Copernican system and Galileo’s telescope helped
revolutionize astronomy. It was Sir Isaac Newton, however, who placed
science on a solid footing by formalizing existing knowledge in terms of
mathematical models and universal laws. In some sense, this was the
real scientific revolution because it permitted prediction of physical
phenomena in a general setting, as opposed to simply describing indi-
vidual observations. The difference is profound.  Whereas a mathemati-
cal equation can adequately describe a given set of observations, it may
be missing the needed universality for making predictions. Kepler’s
equations pertained to planets in our solar system. Newton’s laws could
be used to predict what would happen to two arbitrary bodies any-
where in the universe. The universality of a scientific theory coupled
with mathematical modeling allows us to
make testable predictions. This ability will have
a profound effect on the field of biology.
The hallmarks of a great scientific theory
are universality and simplicity. Newton’s law
of gravity is a case in point. The fact that the
force of attraction between any two bodies is
proportional to the product of their masses
and inversely proportional to the square of the distance between them
is both universal and simple. These issues are especially important
today in the rapidly evolving field of genomics, where formal mathe-
matical and computational methods are becoming indispensable. So
what should be our guiding principles, our beacons of scientific
inquiry? One such fundamental principle underpinning all scientific
investigation is  Ockham’s razor, also called the “law of parsimony.” 
Consider the following, seemingly straightforward problem. We
are presented with a set of data, represented as pairs of numbers (x,y).
In each pair, the first number (x) is an independent variable and the
second number (y) is a dependent variable. The problem is to choose
whether to fit a line (of the form y = a + bx ) or a parabolic function (of
the form y = a + bx + cx2). The knee-jerk response might be as follows:
Let’s fit the parabolic function, since the linear function is clearly a
special case of it, just by letting c = 0; thus, the parabola will always
provide a better fit to our data set. After all, if it so happens that our
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Toxicogenomics is one of the newest fields
of study that will play a major role in future
research breakthroughs in environmental
health. In January, when we expanded
Environmental Health Perspectives’s (EHP)
coverage of this new field by initiating a
new quarterly section of the journal, the
change was welcomed enthusiastically by
the EHP readership. However, to clarify that articles in the
Toxicogenomics Section are part of EHP and not a separate publi-
cation, we have instituted several changes: All articles will now
carry an EHP citation, and each year all sections will have the same
volume number with pages numbered consecutively. Articles will
be abstracted immediately by abstracting services and will enjoy the
same high impact factor as all other EHP articles. So that all arti-
cles in the Toxicogenomics Section have the same citation, we are
re-publishing articles from the premier issue. Note that the Digital
Object Identifier (DOI) code portion of the original citation
remains unchanged.
We will consider articles for publication in the Toxicogenomics
Section of EHP from the related disciplines of pharmacogenomics,
proteomics, metabonomics, bioinformatics, molecular epidemiology,
translational aspects of genomic research, and molecular medicine.
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be published within 24 hours. These arti-
cles are completely citable using the DOI
code that is managed by CrossRef, a
licenseee of the International DOI
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Press articles can be found on our website
(http://ehp.niehs.nih.gov/txg/).
Please join us as we explore the interactions between genes and
the environment and the complexity of the biological circuitry
involved in the cellular response to stressful environments. We will
nurture the field by maintaining the highest standards of excel-
lence. The launching of this new section of EHP marks a critical
stage in the evolution of the field of toxicogenomics. 
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data points are arranged on a line, the estimation of parameters (a, b,
and c) will simply reveal that c is indeed equal to zero and the parabolic
function will reduce to a linear one. Thus, it would seem, three
“adjustable” parameters are better than two. Of course, such reasoning
could be taken ad absurdum if we had freedom to choose as many
parameters as we like. Thus, there must be a tradeoff. Although three
parameters surely provide a better fit to the data, the model becomes
more complex and so, we sacrifice simplicity. But why is that bad?
To give a general answer, by making a model overly complex, we
forfeit predictive accuracy. A complex model may be able to describe
the observed data very well, but will it accurately predict future
instances? For example, if the data contain random fluctuations or
noise, an excessively complex model will “overfit” the data along
with the noise and will obviously provide a poor fit to future
(unseen) data. The chief goal of model selection is to find the right
balance between simplicity and goodness-of-fit. 
Consider gene expression–based cancer classification. The basic
idea is simple: Take a number of tumor samples of a known type,
measure expressions of thousands of genes for each one, and on the
basis of these observations, construct a classifier (model) that will
predict the tumor type when presented with an unknown sample. A
fundamental question is “What type of classifier should we choose?”
This is a crucial step in model selection (in machine learning, the
model is called the “hypothesis space”). The next step—actually
selecting a particular classifier from the model class (i.e., selecting a
particular hypothesis)—is fairly well understood, as it involves the
estimation of parameters.
As discussed, it would be unwise to devise an overly complex clas-
sifier, consisting of hundreds or thousands of parameters, especially in
light of rather small sample sizes (number of tumors) available, which
is typically below 100. Such a classifier may have extremely small or
even no error on the seen data but may exhibit very high error on
unseen data. Hence, its predictive accuracy would be very poor.
So, suitable criteria or methods are needed that would help us
strike the right balance between simplicity and goodness-of-fit, such
that predictive accuracy can be maximized. Fortunately, recent statisti-
cal literature is replete with various approaches, such as the Bayesian
information criterion, Akaike’s information criterion, minimal descrip-
tion length principle, and cross-validation methods. 
In the field of toxicogenomics, issues related to prediction and
model selection are of vital importance. For example, toxicogenomic
biomarkers should reliably predict toxic effects to help us develop
safer drugs and chemicals and understand molecular mechanisms of
pathogenesis. Models of genetic networks and gene expression–based
classifiers are expected to predict consistently a cell’s response to a
stressful challenge and to classify unknown compounds. A keen
awareness of Ockham’s razor will help guide us on our quest to
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As biochemistry students at Aberdeen University in Scotland, our
class studied and strategized together to prepare for our final honors
degree exams, and in the British tradition, the results of those final
exams would, alone, determine our final grade after four years of
undergraduate study. During that final academic year (1973–1974),
the 20th anniversary of the famous Watson and Crick publication
(Watson and Crick 1953) was being loudly celebrated in the scien-
tific literature. Our class predicted that questions about DNA struc-
ture and function would be heavily represented, if not
overrepresented, in the final exams. We were right. Thirty years
later it is an unexpected pleasure to be invited to join the chorus,
indeed the symphony, celebrating the golden anniversary of the
DNA double helix and the sequencing of a complete human
genome and to reflect upon how deciphering the structure of DNA
was fundamental to the fields of mutagenesis and genetic toxicology
and more recently to the emerging field of toxicogenomics.
I have studied various aspects of mutagenesis and genetic toxi-
cology for nearly three decades, and upon looking back at the his-
tory of genetics and molecular biology (wherein Watson and Crick
obviously played a pivotal role), it becomes
immediately apparent that with each
insight into the structure and function of
DNA came an accompanying insight into
how DNA structure and function can go
awry. While Watson and Crick’s discovery
of the complementary nature of the bases
inside the DNA double helix immediately
suggested a mechanism by which DNA could replicate, it did not
suggest how this molecule ultimately dictates the nature of all pro-
teins present in the cell (Watson and Crick 1953). Indeed, even
with an immediate insight into how DNA might replicate, it was 5
years (1958) until the beautiful Meselson and Stahl experiment
(Meselson and Stahl 1958) demonstrated semiconservative DNA
replication, as predicted by Watson and Crick. It was to take 13
years (1966) before the genetic code was finally cracked, and dur-
ing those 13 years there emerged a reasonably complete picture of
how DNA, mRNA, tRNA, and ribosomes collaborate to produce
proteins of genetically predetermined sequence. 
On the 50th Anniversary of Solving 
the Structure of DNA
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. . . just as genetic toxicology co-evolved with the
fields of genetics and molecular biology, so will
toxicogenomics co-evolve with the fields of genomics
and systems biology . . .After the Watson and Crick paper in 1953, along with every
experiment that produced an ever more detailed molecular picture
of how DNA replicates and of how DNA makes RNA makes pro-
teins, there came immediate insights into how each of these
processes can go wrong. For example, until we understood the
workings of triplet codons and the genetic code, we could not
understand (at the molecular level) how changes in the DNA
sequence might ultimately produce missense, nonsense, frameshift,
and other mutations. A detailed understanding of DNA chemistry
also led to an exploration of how chemical and physical agents
could alter that chemistry. From this followed the concept that
damage to DNA might lead to permanent sequence changes and
thus to different kinds of mutation. This is not to say that damage
to cells had not already been shown to cause mutations. Indeed,
Muller demonstrated in 1927 that X-rays could induce heritable
mutations in Drosophila melanogaster, and for this he won the 1946
Nobel Prize in Physiology or Medicine (Muller 1927). But this dis-
covery was 25 years before Hershey and Chase (1952) finally con-
vinced the scientific world that genes reside in DNA, and 26 years
before the structure of DNA was solved (Watson and Crick 1953).
Thus, although the fields of mutagenesis and genetic toxicology
have a history long before the structure of DNA was discovered, it
was only since 1953 that a molecular picture co uld be drawn of
how toxic agents might interact with DNA to produce the biologi-
cal end points of mutation and cytotoxicity. Moreover, the 1953
publication of Watson and Crick launched exquisitely detailed
characterization of how DNA is faithfully replicated, and from this
came an understanding of the role that DNA polymerases and such
processes as recombination must play in the generation of DNA
sequence changes. Parallel to these fundamental revelations were
the observations that all organisms are equipped with a battery of
genes that produce proteins whose primary roles are to prevent or
repair chemical and physical damage to DNA; such activities pro-
tect against mutation and cell death induced by DNA-damaging
agents, and studies of these activities eventually evolved into the
field of genetic toxicology.
Genetic toxicology has been approached in two ways: a) with
questions specifically aimed at understanding the molecular
processes that influence the induction of DNA damage, and the
toxic effects of such DNA damage; and b) with more general ques-
tions about the genes that influence the susceptibility of cells to
toxic agents. The difference between these two approaches lies in
the fact that the first is concerned only with toxicity resulting from
genetic damage, and the second is concerned with genes that influ-
ence the toxicity of an agent, whether or not that toxicity emanates
from damaged DNA. Both of these approaches to genetic toxicol-
ogy are now evolving into the field of toxicogenomics.
With the dawning of the new millennium came one of the
finest achievements in the history of biological research, namely,
the sequencing of a complete human genome. Surely this was one
of the most profound achievements to flow from the 1953 discov-
ery of the structure of DNA. The working draft of this roughly 3.2
billion base pair sequence, the technological advances that were
developed because of it, and the rapid electronic publication of the
sequence as it was generated changed forever the ways in which
biological and health-related research is being conducted. It is now
possible, in principle, to address questions about all human genes
in a massively parallel way, that is, questions related to the entire
human genome, hence the term “genomics.” The National
Institute of Environmental Health Sciences (NIEHS) was very
quick to realize the awesome potential of being able to interrogate
the role of each and every gene in protecting humans against the
detrimental health effects of exposure to environmental agents. The
prescience of the NIEHS led to the launch of two major extra-
mural research initiatives that have fostered the application of
genomics to the environmental health sciences, namely, the
Environmental Genome Project and the Toxicogenomics Research
Consortium. 
Several years ago the NIEHS established the Environmental
Genome Project (http://www.niehs.nih.gov/envgenom/home.htm)
to identify all common DNA variants, mainly single nucleotide
polymorphisms (SNPs) for more than 500 human genes known (or
likely) to influence cellular responses to toxic environmental
agents. In the long term we will have an inventory of common
SNPs for every gene in the human genome, but in the short term
the Environmental Genome Project will provide us with focused
information for genes already known to influence the biological
consequences of exposure to toxic environmental agents. It is not
difficult to imagine that it will soon be possible to screen individu-
als to determine their constellation of SNPs in these 500 or so
genes deemed relevant to environmentally induced disease. This
foray into genomic scale analysis will provide an important first
step toward our being able to predict the response of an individual
upon exposure to toxic environmental agents. However, it is quite
clear that being able to identify the gene variants present in an
organism is simply not enough. Genomic analyses must stretch far
beyond the DNA to include RNA and protein; after all, DNA
makes RNA makes protein. It is clear that we need to know the
temporal aspects of how the environmentally relevant genes are
expressed (in each cell type), as well as how their expressed prod-
ucts (RNA and protein) are modified and localized in the cell. We
also must be able to predict how such expression, modification,
and localization will change over time when individuals are
exposed to environmental agents. Finally, armed with all this
knowledge we must learn how to integrate the information into a
systems biology view that not only is descriptive but also is predic-
tive of the phenotype of cells, tissues, and ultimately people. We
have not yet grasped how to do this, but we will have achieved one
of the most exciting and powerful insights into biology when we
find the ways.
The field of toxicogenomics has thus emerged to address these
genomic-scale questions; moreover, the National Center for
Toxicogenomics at the NIEHS recently established the
Toxicogenomics Research Consortium (http://www.niehs.
nih.gov/nct/trc.htm) to help launch and foster the development of
the field. At the very least, transcriptional profiling using DNA
microarrays and proteomic analysis using mass spectrometry repre-
sent the current major thrusts in toxicogenomics. In addition, the
development of genomic approaches to systematically assess how
each gene influences the phenotypic response of cells to environ-
mental agents is well under way for model organisms such as
Saccharomyces cerevisiae, and such “genomic phenotyping” is now
being initiated for mammalian cells. It seems likely that within the
next few years, libraries of small inhibitory RNAi constructs will be
available for the systematic knock down of expression for each and
every human gene in each of many different human cell types. It is
inevitable that the fields of genomics and systems biology will
mature as more efficient and sophisticated technologies emerge for
quantitatively measuring global gene expression, global RNA and
protein modification, and the dynamic trafficking and localization
of cellular molecules. And just as genetic toxicology co-evolved
with the fields of genetics and molecular biology, so will toxicoge-
nomics co-evolve with the fields of genomics and systems biology. 
The future test of toxicogenomics will be in our ability to pre-
dict accurately human susceptibility to the adverse effects of envi-
ronmental agents. Perhaps, long before the golden anniversary of
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sequencing the human genome, it will be possible to determine
individualized risk to environmental agents as part of a routine
annual checkup. But before a time-line for this can even be envi-
sioned, we must first learn to apply quantitative molecular assess-
ments, engineering principles, and the informatics tools necessary to
conduct successful predictive toxicology in model cellular systems.
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